Publications by authors named "Russell S Scott"

Claim this Profile
P
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3.
Luke J Laffin, Stephen J Nicholls, Russell S Scott, Peter M Clifton, John Baker

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of haptoglobin levels and phenotype with cardiovascular disease in Type 2 diabetes: a Fenofibrate Intervention and Event Lowering in Diabetes sub-study.
Kwok Leung Ong, Andrzej S Januszewski, Habib Francis, Rachel L O'Connell, Abubakar Mangani, Russell S Scott

Eur J Prev Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of haptoglobin phenotype and levels with sight-threatening diabetic retinopathy in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in diabetes (FIELD) substudy.
Kwok Leung Ong, Andrzej S Januszewski, Habib Francis, Rachel L O'Connell, Abubakar Mangani, Russell S Scott

Diabetes Res Clin Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate.
Andrzej S Januszewski, Hayden K Young, Kwok-Leung Ong, Liping Li, Rachel L O'Connell, Russell S Scott

J Diabetes Investig· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not enough known about fenofibrate's kidney effects in people with Type 2 diabetes.
Alicia J Jenkins, Rachel L O'Connell, Andrzej S Januszewski, Angela C Webster, Timothy M E Davis, Russell S Scott

Diabetes Res Clin Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study.
Kwok-Leung Ong, Liang Wu, Andrzej S Januszewski, Rachel O'Connell, Aimin Xu, Russell S Scott

Diab Vasc Dis Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes.
Andrzej S Januszewski, David Chen, Russell S Scott, Rachel L O'Connell, Nanda R Aryal

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study.
Jacob Y Cao, Boris Waldman, Rachel O'Connell, David R Sullivan, Russell S Scott

Diabetes Obes Metab· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease.
Robert J Mentz, Vivian P Thompson, David Aguilar, Jasmine Choi, Stephanie M Gustavson, Russell S Scott

Circulation· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.
Boris Waldman, Jean-Claude Ansquer, David R Sullivan, Alicia J Jenkins, Neil McGill, Russell S Scott

Lancet Diabetes Endocrinol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study.
Kwok-Leung Ong, Rachel O'Connell, Andrzej S Januszewski, Alicia J Jenkins, Aimin Xu, Russell S Scott

Clin Chem· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.
Kwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, Luke Buizen, Alicia J Jenkins, Russell S Scott

Diabetologia· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.
Kwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, Alicia J Jenkins, Aimin Xu, Russell S Scott

Diabetologia· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic comparison of a generic coenzyme Q₁₀ solubilizate and a formulation with soybean phytosterols.
Joanna M Young, Sarah L Molyneux, Christopher M Florkowski, Christopher M Frampton, Peter M George, Russell S Scott

Phytother Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome.
Joanna M Young, Christopher M Florkowski, Sarah L Molyneux, Roberta G McEwan, Christopher M Frampton, Russell S Scott

Am J Hypertens· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy.
Joanna M Young, Sarah L Molyneux, Annette M Reinheimer, Christopher M Florkowski, Christopher M Frampton, Russell S Scott

Atherosclerosis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ABCA1 truncation shows no dominant negative effect in a familial hypoalphalipoproteinemia pedigree with three ABCA1 mutations.
Brie Sorrenson, Rachel J Suetani, Vivienne M Bickley, Peter M George, Michael J A Williams, Russell S Scott

Biochem Biophys Res Commun· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urban-rural variation in childhood type 1 diabetes incidence in Canterbury, New Zealand, 1980-2004.
Laura J Miller, Jinny A Willis, Jamie Pearce, Ross Barnett, Brian A Darlow, Russell S Scott

Health Place· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrates plus betaine: a winning combination?
Michael Lever, Peter M George, Sandy Slow, Jane L Elmslie, Brett I Shand, Russell S Scott

N Z Med J· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative glycaemic impact of customarily consumed portions of eighty-three foods measured by digesting in vitro and adjusting for food mass and apparent glucose disposal.
John A Monro, Alison Wallace, Suman Mishra, Sarah Eady, Jinny A Willis, Russell S Scott

Br J Nutr· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.
Richard I King, Russell S Scott, Christopher M Florkowski, Andrew D Laurie, Nicola Reid

N Z Med J· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine.
Michael Lever, Peter M George, Sandy Slow, Jane L Elmslie, Russell S Scott

Cardiovasc Drugs Ther· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability in measurements of blood glucose response to foods in human subjects is not reduced after a standard breakfast.
Alison J Wallace, Sarah L Eady, Jinny A Willis, Russell S Scott, John A Monro

Nutr Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is population mixing associated with childhood type 1 diabetes in Canterbury, New Zealand?
Laura J Miller, Jamie Pearce, Ross Barnett, Jinny A Willis, Brian A Darlow, Russell S Scott

Soc Sci Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Jane L Elmslie, Richard J Porter, Peter R Joyce, Penelope J Hunt, Brett I Shand, Russell S Scott

Aust N Z J Psychiatry· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis